Eisai
4523.T
#2149
Rank
A$13.14 B
Marketcap
A$46.62
Share price
1.81%
Change (1 day)
3.18%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.22. an increase over its 2024 EPS that were of A$1.37.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.5311.85%
2024A$1.37-32.63%
2023A$2.045.52%
2022A$1.93-74.01%
2021A$7.42-66.58%
2020A$22.2198.24%
2019A$11.2117.01%
2018A$9.5837.78%
2017A$6.95-27.62%
2016A$9.6035.33%
2015A$7.10-2.82%
2014A$7.30-27.66%
2013A$10.10-27.49%
2012A$13.92-12.67%
2011A$15.9488.08%
2010A$8.48-11.06%
2009A$9.53-390.15%
2008A-$3.29-127.78%
2007A$11.8311.78%
2006A$10.584.38%
2005A$10.147.4%
2004A$9.4443.03%
2003A$6.6025.09%
2002A$5.2852.67%
2001A$3.4669.76%
2000A$2.04